Showing results (2801-2810 of 6,780) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|June 6, 2006
Managing the symptoms of multiple sclerosis: a multimodal approachHeidi J Crayton, Howard S RossmanClinical Therapeutics|June 6, 2006
Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomniaJadwiga NajibClinical Therapeutics|June 6, 2006
A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adultsJeanette Wendt, Roger Cady, Richard Singer, et al.Clinical Therapeutics|June 6, 2006
A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertensionRicardo Reis, Carlos F Queiroz, Lúcia C Santos, et al.Clinical Therapeutics|June 6, 2006
Drugs and falls in community-dwelling older people: a national veterans studyDustin D French, Robert Campbell, Andrea Spehar, et al.Clinical Therapeutics|October 26, 2006
Intervention strategies for neonatal hypoxic-ischemic cerebral injuryJeffrey M PerlmanClinical Therapeutics|October 26, 2006
Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilizationPatricia A Caetano, Jonathan M C Lam, Steven G MorganClinical Therapeutics|October 26, 2006
Dosing patterns and costs of erythropoietic agents in patients with chronic kidney disease not on dialysis in managed care organizationsMei Sheng Duh, Samir H Mody, R Scott McKenzie, et al.Clinical Therapeutics|May 9, 2006
Echinacea in the prevention of induced rhinovirus colds: a meta-analysisRoland Schoop, Peter Klein, Andy Suter, et al.Clinical Therapeutics|August 4, 2010
Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group studySuzanne Oparil, Michael Melino, James Lee, et al.Pageof 678